| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-121 |
Sentence |
denotes |
Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma. |
| T1 |
0-121 |
Sentence |
denotes |
Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma. |
| TextSentencer_T2 |
122-133 |
Sentence |
denotes |
BACKGROUND: |
| T2 |
122-133 |
Sentence |
denotes |
BACKGROUND: |
| TextSentencer_T3 |
134-241 |
Sentence |
denotes |
Hepatocellular carcinoma (HCC) has a dismal 5-year-survival rate of 10%, so novel strategies are warranted. |
| T3 |
134-241 |
Sentence |
denotes |
Hepatocellular carcinoma (HCC) has a dismal 5-year-survival rate of 10%, so novel strategies are warranted. |
| TextSentencer_T4 |
242-400 |
Sentence |
denotes |
IL-24 mediates anti-tumor activity reducing STAT3 expression, which suggests that interferon (IFN) alpha may augment tumor cell lysis and reduce angiogenesis. |
| T4 |
242-400 |
Sentence |
denotes |
IL-24 mediates anti-tumor activity reducing STAT3 expression, which suggests that interferon (IFN) alpha may augment tumor cell lysis and reduce angiogenesis. |
| TextSentencer_T5 |
401-563 |
Sentence |
denotes |
We investigated the antitumor activity of treatment with IFN-α, with the oncolytic adenovirus SG600-IL-24, or the combination of both in HCC in vitro and in vivo. |
| T5 |
401-563 |
Sentence |
denotes |
We investigated the antitumor activity of treatment with IFN-α, with the oncolytic adenovirus SG600-IL-24, or the combination of both in HCC in vitro and in vivo. |
| TextSentencer_T6 |
564-710 |
Sentence |
denotes |
RESULTS: RT-PCR, ELISA assay and Western-blot confirmed that the exogenous IL-24 gene was highly expressed in HCC cells infected with SG600-IL-24. |
| T6 |
564-710 |
Sentence |
denotes |
RESULTS: RT-PCR, ELISA assay and Western-blot confirmed that the exogenous IL-24 gene was highly expressed in HCC cells infected with SG600-IL-24. |
| TextSentencer_T7 |
711-882 |
Sentence |
denotes |
Treatment with combined IFN-α and SG600-IL-24 suppressed growth and promoted apoptosis of the HepG2, MHCC97L, and HCCLM3 cell lines compared with the normal cell line L02. |
| T7 |
711-882 |
Sentence |
denotes |
Treatment with combined IFN-α and SG600-IL-24 suppressed growth and promoted apoptosis of the HepG2, MHCC97L, and HCCLM3 cell lines compared with the normal cell line L02. |
| TextSentencer_T8 |
883-1095 |
Sentence |
denotes |
The combined therapy increased STAT1 and SOCS1 and apoptosis, but decreased the expression of the metastatic and angiogenic proteins MMP-2, XIAP, OPN, and VEGF, which are regulated by STAT3 in HCC cells in vitro. |
| T8 |
883-1095 |
Sentence |
denotes |
The combined therapy increased STAT1 and SOCS1 and apoptosis, but decreased the expression of the metastatic and angiogenic proteins MMP-2, XIAP, OPN, and VEGF, which are regulated by STAT3 in HCC cells in vitro. |
| TextSentencer_T9 |
1096-1219 |
Sentence |
denotes |
To assess the effects in vivo, the HCC cell line HCCLM3 was transplanted subcutaneously into the right flanks of nude mice. |
| T9 |
1096-1219 |
Sentence |
denotes |
To assess the effects in vivo, the HCC cell line HCCLM3 was transplanted subcutaneously into the right flanks of nude mice. |
| TextSentencer_T10 |
1220-1406 |
Sentence |
denotes |
Mice in the IFN-α group, the SG600-IL-24 group, or the combined therapy group had significantly suppressed growth of the HCC xenografted tumors compared to the PBS control group of mice. |
| T10 |
1220-1406 |
Sentence |
denotes |
Mice in the IFN-α group, the SG600-IL-24 group, or the combined therapy group had significantly suppressed growth of the HCC xenografted tumors compared to the PBS control group of mice. |
| TextSentencer_T11 |
1407-1553 |
Sentence |
denotes |
Among the mice treated with the combination of IFN-α and SG600-IL-24, three of those eight mice had long-term survival and no evidence of a tumor. |
| T11 |
1407-1553 |
Sentence |
denotes |
Among the mice treated with the combination of IFN-α and SG600-IL-24, three of those eight mice had long-term survival and no evidence of a tumor. |
| TextSentencer_T12 |
1554-1664 |
Sentence |
denotes |
These mice also had decreased expression of the metastatic and angiogenic proteins MMP-2, XIAP, OPN, and VEGF. |
| T12 |
1554-1664 |
Sentence |
denotes |
These mice also had decreased expression of the metastatic and angiogenic proteins MMP-2, XIAP, OPN, and VEGF. |
| TextSentencer_T13 |
1665-1677 |
Sentence |
denotes |
CONCLUSIONS: |
| T13 |
1665-1677 |
Sentence |
denotes |
CONCLUSIONS: |
| TextSentencer_T14 |
1678-1945 |
Sentence |
denotes |
The present study demonstrated for the first time the potential antitumor activity of IFN-α combined with the oncolytic adenovirus SG600-IL-24 in HCC both in vitro and in vivo, and suggests its further development as a potential candidate for HCC cancer gene therapy. |
| T14 |
1678-1945 |
Sentence |
denotes |
The present study demonstrated for the first time the potential antitumor activity of IFN-α combined with the oncolytic adenovirus SG600-IL-24 in HCC both in vitro and in vivo, and suggests its further development as a potential candidate for HCC cancer gene therapy. |